Small Molecules
30 August 2013
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide)30 August 2013
Trigemina Presents Data on Intranasal Oxytocin for the Treatment of Trigeminal Neuralgia30 August 2013
Bayer’s Stivarga® (regorafenib) Approved in the EU for the Treatment of Metastatic Colorectal Cancer29 August 2013
Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis29 August 2013
New Drug Application Filing for Ibrutinib Accepted in Two B-cell Malignancies by the U.S. FDA29 August 2013
Can-Fite to Initiate a Phase II Study With CF102 in 130 Patients With Advanced Liver Cancer29 August 2013
PharmaEngine Announces Achieving Patient Enrollment Goal in the Phase III Metastatic Pancreatic Cancer Study of PEP02 (MM-398)29 August 2013
Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension28 August 2013
Orexo Reports Successful Completion of OX51 Phase II Dose-Finding Study in Prevention of Procedure-Induced Pain28 August 2013
Acucela Reaches 50% Enrollment in the Emixustat Hydrochloride Phase 2b/3 Clinical Trial27 August 2013
Catalyst Pharmaceutical Partners Receives Breakthrough Therapy Designation From FDA for Firdapse(TM) for the Treatment of LEMS27 August 2013
Karolinska Development AB (publ): Lipidor reports positive clinical Phase I/II data in psoriasis27 August 2013
Acura Pharmaceuticals Announces Top-Line Results of a Clinical Study Assessing Abuse Liability27 August 2013
Congenia Announces Enrollment of First Healthy Volunteer in Phase 1 Clinical Trial of GNX-508627 August 2013
Nexavar® (sorafenib) Granted Priority Review for Differentiated Thyroid Cancer in the U.S.News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports